Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease
- 1 October 2006
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 27 (10) , 546-553
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- An Immune Basis for Lung Parenchymal Destruction in Chronic Obstructive Pulmonary Disease and EmphysemaPLOS Medicine, 2004
- The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2004
- Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cellsJournal of Leukocyte Biology, 2003
- Regulation of TNF‐α and IFN‐γ induced CXCL10 expression: participation of the airway smooth muscle in the pulmonary inflammatory response in chronic obstructive pulmonary diseaseThe FASEB Journal, 2003
- Ligand-independent CXCR2 DimerizationJournal of Biological Chemistry, 2003
- Structure-Function Relationship between the Human Chemokine Receptor CXCR3 and Its LigandsJournal of Biological Chemistry, 2003
- Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysemaThorax, 2002
- Identification of the Binding Site for a Novel Class of CCR2b Chemokine Receptor AntagonistsJournal of Biological Chemistry, 2000
- Increased MCP-1 and MIP-1β in bronchoalveolar lavage fluid of chronic bronchiticsEuropean Respiratory Journal, 1999
- Neutrophil chemokines in bronchoalveolar lavage fluid and leukocyte-conditioned medium from nonsmokers and smokersEuropean Respiratory Journal, 1998